期刊文献+

马来酸罗格列酮对2型糖尿病患者血压的影响

下载PDF
导出
摘要 目的观察胰岛素增敏剂马来酸罗格列酮对2型糖尿病(T2DM)合并高血压患者的降压效果。方法42例2型糖尿病患者,未服用任何降压药物,分为合并高血压和血压正常两组,均服用罗格列酮4mg/日,疗程8周。每周测量坐位血压1次,空腹、餐后血糖在试验前、第四周结束及第8周结束时各测定1次。结果高血压组用药8周后血压明显降低(P<0.01),正常血压组较治疗前血压有所降低,但差异无统计学意义(P>0.05)。结论马来酸罗格列酮作为胰岛素增敏剂,对T2DM合并高血压患者除降低血糖外还有降低血压的作用。
作者 马骏
出处 《福建医药杂志》 CAS 2008年第1期42-43,共2页 Fujian Medical Journal
  • 相关文献

参考文献11

  • 1李光伟,王金平,李春梅,陈燕燕,杨文英,邢小燕,刘克莉,唐玉龙,黎辉.胰岛素增敏剂罗格列酮抗高血压作用探讨[J].中华内科杂志,2004,43(12):907-910. 被引量:55
  • 2Shargorodsky M, Wainstein J, Gavish D, et al. Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus. Am J Hypertens, 2003, 16 (8): 617-622.
  • 3Sarafidis PA, Lasaridis AN, Nilsson PM, et al. Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. J Hypertens, 2004, 22 (9): 1769-1777.
  • 4孙雅逊,胡申江.列酮类药物与高血压[J].国际心血管病杂志,2006,33(2):86-89. 被引量:9
  • 5Eto K, Ohya Y, Nakamura Y, et al. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. Eur J Pharmacol, 2001, 423 (1): 1.
  • 6Raji A, Seely EW, Bekins SA, et al. Rosiglitazone improves insulin sensitivity and lowers blood pressure hypertensive patients. Diabetes Care, 2003, 26 (1): 172.
  • 7Iglarz M, Touyz RM, Amiri F, et al. Effect of peroxisome proliferator-activated receptor-a (and-) actiators on vascular remodeling in endothelin-dependent hypertension. Arterioscler Thromb VascBiol, 2003. 23 (1).. 45.
  • 8Diep QN, Mabrouk M, Cohn JS, et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin Ⅱ -infused rates: role of peroxisome proliferators-activated receptor-gamma. Circulation, 2002, 105 (19):2296.
  • 9Law RE, Goetze S, XIXP, et al. Expression and function of PPAR gamma in rat and human vascular smooth muscle cells. Circulation, 2000, 101 (11): 1311.
  • 10Knock GA, Mishra SK, Araonson PI. Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes. Eur J Pharnzacol, 1999, 368 (1) :103.

二级参考文献34

  • 1[1]Kemnitz JW,Elson DF.Roecker EB,et al.Pioglitazone increases insulin sensitivity,reduces blood glucose,insulin,and lipid levels,and lowers blood pressure,in obese,insulin-resistant rhesus monkeys[J].Diabetes,1994,43 (2):204-211.
  • 2[2]Ogihara T,Rakugi H,Ikegami H,et al.Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives[J].Am J Hypertens,1995,8(3):316-320.
  • 3[3]Yoshioka S,Nishino H,Shiraki T,et al.Antihypertensive effects of CS-045 treatment in obese Zucker rats[J].Metabolism,1993,42 (1):75-80.
  • 4[4]Yoshimoto T,Naruse M,Nishikawa M,et al.Antihypertensive and vasculo-and renoprotective effects of pioglitazone in genetically obese diabetic rats[J].Am J Physiol,1997,272(6 Pt 1):E989-E996.
  • 5[5]Buchanan TA,Meehan WP,Jeng YY,et al.Blood pressure lowering by pioglitazone.Evidence for a direct vascular effect[J].J Clin Invest,1995,96(1):354-360.
  • 6[6]Nolan JJ,Ludvik B,Beerdsen P,et al.Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone[J].N Engl J Med,1994,331 (18):1188-1193.
  • 7[7]Ledingham JM,Laverty R.Effects of glitazones on blood pressure and vascular structure in mesenteric resistance ar teries and basilar artery from genetically hypertensive rats[J].Clin Exp Pharmacol Physiol,2005,32(11):919,925.
  • 8[8]Barroso I,Gurnell M,Crowley VE,et al.Dominant negative mutations in human PPARgamma associated with severe insulin resistance,diabetes mellitus and hypertension[J].Nature,1999,402(6764):880-883.
  • 9[9]Savage DB,Tan GD,Acerini CL,et al.Human metabolic syndrome resulting from dominant negative mutations in the nuclear receptor peroxisome proliferator-activated receptor gamma[J].Diabetes,2003,52(4):910-917.
  • 10[10]Walker AB,Chattington PD,Buckingham RE,et al.The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats[J].Diabetes,1999,48(7):1448-1453.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部